2010 SFO rapport focuses on complex management of uveitis

June 2010
Ocular Surgery News;6/25/2010, Vol. 28 Issue 12, p18
Academic Journal
The article provides information about the complex management of uveitis, according to Antoine Brézin, coordinator of the 2010 SFO rapport on uveitis.


Related Articles

  • Vision system enables easy transition to coaxial MICS. Packer, Mark // Ophthalmology Times;9/1/2008, Vol. 33 Issue 17, p12 

    The article focuses on the study conducted by cataract surgeon Dominique Monnet, which revealed that enhancement systems performing coaxial microincision cataract surgery (C-MICS) enables safe and efficient phacoemulsification. According to Monnet and Antoine Brézin's evaluation on the first...

  • Consider referral for uveitis. Sweeney, Tara // Ophthalmology Times;8/15/96, Vol. 21 Issue 22, p16 

    Reports that delayed referral is one of the factor for the decreased outcome in uveitis treatment, according to Stephen Foster of the Massachusetts Eye & Ear Infirmary (MEEI) in Boston. Responsibility of general ophthalmologist to refer uveitis patients for multiple recurrences, granulomatous...

  • Uveitis and rifabutin therapy.  // American Family Physician;11/1/1994, Vol. 50 Issue 6, p1391 

    Reports that rifabutin (Myscobutin) therapy is associated with the development of uveitis. Recommendation of the U.S. Public Health Service Task Force n 1993 of rifabutin; Possibility of uveitis on administration of higher doses of rifabutin.

  • Metoprolol responding uveitis: reply. Kassif, Y; Rehany, U; Rumelt, S // Eye;Jun2005, Vol. 19 Issue 6, p720 

    Presents a letter to the editor in response to a comment about the use of metoprolol for uveitis.

  • Metoprolol responding uveitis. Masood, I // Eye;Jun2005, Vol. 19 Issue 6, p719 

    Presents a letter to the editor referring to a case of panuveitis responding to oral metoprolol therapy.

  • Management of Immune-Mediated Uveitis. Smith, J.R.; Rosenbaum, J.T. // BioDrugs;2000, Vol. 13 Issue 1, p9 

    Immune-mediated uveitis is a collective term referring to a group of potentially blinding intraocular inflammations which may coexist with systemic inflammatory diseases. T lymphocytes appear to play an important pathogenic role in uveitis, and these cells are therefore the logical target of...

  • Treat early and embrace the evidence in favour of anti-TNF-α therapy for Behçet's uveitis. Lee, Richard W. J.; Dick, Andrew D. // British Journal of Ophthalmology;Mar2010, Vol. 94 Issue 3, p2 

    The author reflects on the need to embrace medical developments in favor of the anti-tumour necrosis factor therapy for the treatment of Behcet's uveitis.

  • Speaker shares experiences managing uveitis.  // Ocular Surgery News;2/25/2014, Vol. 32 Issue 4, p29 

    The article discusses the experience of ophthalmologist Dr. Thomas A. Albini in making a decision to treat tuberculosis when there is high degree of suspicion that a patient has tuberculosis despite obtaining negative sputum test result, using leopard spots detected on ocular imaging as a clue.

  • Cancer-causing Drug Treats Uveitis.  // Review of Ophthalmology;Mar2002, Vol. 9 Issue 3, p11 

    Focuses on the effectiveness of chlorambucil in treating uveitis in the Chicago, Illinois. Percentage rate of treated patients experience on recurrence of uveitis; Number of patients treated with high-dose, short-term chlorambucil; Prohibition of drugs for long-term use.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics